The drug company says the problem involved one batch of a substance that goes into its coronavirus vaccine. But the contractor, Emergent BioSolutions, has a history of problems.
Copyright 2021 NPR
The drug company says the problem involved one batch of a substance that goes into its coronavirus vaccine. But the contractor, Emergent BioSolutions, has a history of problems.
Copyright 2021 NPR